Given the serious nature and number of Beovu side effects reported to date, together with the Beovu lawsuits filed against Novartis for patients with severe vision loss, it seems fair to say that things look a bit grim for Beovu and Novartis at the start of 2021. So what does the path forward look like for Beovu?
Let’s start with where things stand today:
- Like Eylea and Lucentis, Beovu injections are used for treatment of neovascular (wet) age-related macular degeneration (AMD).
- However, Beovu side effects such as occlusive retinal vasculitis, retinal artery occlusion, and intraocular inflammation have resulted in vision loss and blindness.
- Starting in January 2021 Beovu lawsuits have been filed for patients alleging Novartis failed to adequately warn about these serious Beovu side effects.
- Given this situation, some eye doctors are avoiding Beovu when treating their AMD patients.
A possible indication of the Novartis strategy for battling back from this less-than-ideal current posture can be found in a “Novartis Fourth Quarter and Full Year 2020 Condensed financial report – Supplementary Data” document:
Post marketing cases termed as “intraocular inflammation.” and/or “retinal vascular occlusion” that may result in severe vision loss, typically associated with intraocular inflammation and the current COVID-19 situation had an unfavorable impact on sales. Novartis has a comprehensive plan, in strong collaboration with leading external global experts to educate the retina community about the positive benefit / risk profile of Beovu.
It seems that this Novartis plan to get Beovu back on the path of being a so-called “blockbuster” drug for Novartis in terms of sales might involve its external safety review committee (SRC). In the past, Novartis has implied that this panel of experts was set up to provide an independent review of the Beovu side effects case reports.
Our law firm is investigating possible Beovu lawsuits for patients who have suffered vision loss or blindness due to Beovu side effects. If we can be of assistance to you or someone else regarding a Beovu drug injury case, you can submit a Case Evaluation Form online or you can call us on our toll-free number: 800-426-9535.[View article at original source]